Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts
Author:
Meghan E. McGee-Lawrence,Angela L. McCleary-Wheeler,Frank J. Secreto,David F. Razidlo,Minzhi Zhang,Bridget A. Stensgard,Xiaodong Li,Gary S. Stein,Jane B. Lian,Jennifer J. Westendorf
Copyright © 2011 Elsevier Inc. All rights reserved.